- Russell Mannion, director 1,
- Huw T O Davies, director 2
- 1Centre for Health and Public Services Management, University of York, York YO10 5DD
- 2Social Dimensions of Health Institute, Universities of Dundee and St Andrews
- Correspondence to: R Mannion rm15{at}york.ac.uk
- Accepted 14 November 2007
Health service pay is top of the political and media agenda in many countries. In the UK, moral outrage over doctors’ pay - fuelled by the lay media - has contributed to a widespread belief that pay rises have soaked up much of the recent investment in the NHS.1 Doctors’ representatives respond that rising pay reflects rising quality and performance, but doubts remain and even the government has expressed alarm, threatening to cap future rises. Other countries are also grappling with how to pay healthcare professionals, particularly doctors.
Pay and performance
Many countries have linked the remuneration problem with concerns about quality and performance, focusing new attention on payment for performance programmes. Under these programmes a portion of payment is dependent on performance assessed against one or more defined measures.2 The United States has over 100 private and federal Medicare reward and incentive programmes,3 and Italy and New Zealand are beginning to reward performance in primary care. The UK remains in the vanguard of such schemes, with the quality and outcomes framework paying out around £1000m (€1300m;$2000m) in 2005-6 to general practices4 and being described at its launch as the “boldest such proposal on this scale ever attempted anywhere in the world.”5
Paying for performance is being given increasing attention across many public services, as a means of motivation and drawing attention to local agency.6 Beyond these larger trends, many reasons have been given for linking doctors’ pay to performance (box 1). Taken together, these arguments have contributed to a lessening of ideological debate with much of the deliberation now …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012